Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $77 | $89 | $1 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $47 | $45 | $40 | $33 |
| Inventory | $62 | $47 | $41 | $0 |
| Other Curr. Assets | $32 | $34 | -$159 | -$33 |
| Total Curr. Assets | $218 | $215 | $1 | $1 |
| Property Plant & Equip (Net) | $90 | $69 | $0 | $1 |
| Goodwill | $47 | $2 | $3 | $3 |
| Intangibles | $9 | $7 | $7 | $7 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $4 | $4 | $0 | $0 |
| Other NC Assets | $53 | $50 | -$9 | -$9 |
| Total NC Assets | $204 | $131 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $422 | $346 | $2 | $2 |
| Liabilities | – | – | – | – |
| Payables | $19 | $17 | $16 | $14 |
| Short-Term Debt | $7 | $5 | $4 | $8 |
| Tax Payable | $7 | $7 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $62 | $58 | -$26 | -$24 |
| Total Curr. Liab. | $95 | $87 | $1 | $1 |
| LT Debt | $43 | $5 | $8 | $13 |
| Deferred Rev, NC | $0 | $3 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $2 | $1 | $2 |
| Other NC Liab. | $11 | $3 | $6 | $5 |
| Total NC Liab. | $56 | $12 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $150 | $99 | $1 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $7 | $7 | $0 |
| Retained Earnings | $228 | $209 | $184 | $1 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $35 | $31 | $19 | $0 |
| Total Equity | $260 | $246 | $2 | $1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $11 | $1 | $0 | $0 |
| Total Liab. & Tot. Equity | $422 | $346 | $2 | $2 |
| Net Debt | -$27 | -$79 | $11 | $21 |